Arena Pharmaceuticals Falls on Wider-than-Expected Q2 Loss
Arena Pharmaceuticals, Inc. ( ARNA ) fell approximately 3.7% after the company reported a net loss (excluding one-time items) of 12 cents per share in the second quarter of 2014 wider than the Zacks Consensus Estimate of loss of 11 cents. Arena had reported earnings of 17 cents per share in the year-ago quarter […]